What are the recommendations for vaccination against pertussis (whooping cough)?

Updated: May 02, 2019
  • Author: Joseph J Bocka, MD; Chief Editor: Russell W Steele, MD  more...
  • Print
Answer

In December 2005, the American Academy of Pediatrics approved recommendations from the Committee on Infectious Diseases (COID) for universal vaccination of adolescents at the 11- or 12-year visit to boost protection against pertussis. [34, 35] The FDA has licensed 2 tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) products for use in children aged 10-18 years (Boostrix; GlaxoSmithKline Biologicals, Rixensart, Belgium) and for patients aged 11-64 years (Adacel; Sanofi Pasteur, Toronto, Canada). Tdap has replaced tetanus in the childhood and adult immunization schedules. It has been shown to be effective in outbreaks in the short term. Long-term effectiveness studies are ongoing.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!